Andrew Farquharson, Director at Rani Therapeutics Holdings, Inc. (RANI), sold 160,504 shares at $10.51 ($1.7M) on 2022-08-17, disclosed to the SEC on 2022-08-19.
Open-market sale of $1.7M RANI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.51 | 71,042 | $747K | 43.7% |
| 2 | $10.51 | 71,042 | $747K | 43.7% |
| 3 | $11.62 | 9,210 | $107K | 6.3% |
| 4 | $11.62 | 9,210 | $107K | 6.3% |
| Total | $10.64 avg | 160,504 | $1.7M | 100% |